Home » Health » Cuba studies the safety of its Abdala anticovid vaccine in children aged 6 to 11 months | Society | America Edition

Cuba studies the safety of its Abdala anticovid vaccine in children aged 6 to 11 months | Society | America Edition

Cuba is studying the safety and effectiveness of its Abdala anticovid vaccine in children between six and eleven months old, those responsible for the investigation reported this Tuesday, quoted by state media.

If successful, it would be one of the first formulas against covid-19 worldwide in children under one year of age. Cuba is immunizing its entire population from the age of two with nationally produced vaccines.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.